Prions, BSE and food

International Journal of Food Microbiology

Volumn 78, Issue 1-2, 2002, Pages 181-189

  Dormont, Dominique ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

BSE; Molecular markers; Prions; Risk assessment; TSE; Variant of Creutzfeldt Jakob Disease (cCJD)

Indexed keywords

MOLECULAR MARKER; PRION PROTEIN; BIOLOGICAL MARKER;

BIOCHEMISTRY; BOVINE SPONGIFORM ENCEPHALOPATHY; CLINICAL FEATURE; CORRELATION ANALYSIS; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; HUMAN; INFECTION; MOLECULAR BIOLOGY; NONHUMAN; PRION; PRION DISEASE; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; VIRUS INACTIVATION; ANIMAL; CATTLE; ISOLATION AND PURIFICATION; PATHOGENICITY; PHYSIOLOGY; SAFETY; ZOONOSIS;

BOVINAE;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CONSUMER PRODUCT SAFETY; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; PRION DISEASES; PRIONS; RISK ASSESSMENT; ZOONOSES;

EID: 0037105001     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(02)00240-4     Document Type: Article

References (65)

1. MS-8209, a new amphotericin B derivative provides enhanced efficacy in delaying hamster scrapie
2. Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: Implications for the mechanism of action of polyene antibiotics
3. Incidence of Creutzfeldt-Jakob Disease in Europe in 1993
4. Early accumulation of PrP(sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie
5. Experimental transmission of BSE and scrapie to the common marmoset
6. A modified host protein model of scrapie
7. Prions in skeletal muscle
8. Epidemiology and control of bovine spongiform encephalopathy (BSE)
9. Normal host prion protein necessary for scrapie-induced neurotoxicity
10. Laboratory and hospital disinfection of spongiform encephalopathy viruses
11. Creutzfeldt-Jakob disease of long duration: Clinico-pathological characteristics, transmissibility, and differential diagnosis
12. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue
13. Friendly fire in medicine - Hormones, homografts, and Creutzfeldt-Jakob disease
14. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: Implications for the nature of the agent and host control of pathogenesis
15. Transmission of bovine spongiform encephalopathy and scrapie to mice: Strain variation and the species barrier
16. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
17. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues
18. Normal development and behaviour of mice lacking the neuronal cell surface PrP protein
19. Mice devoid of PrP are resistant to scrapie
20. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man
21. Structural clues to prion replication
22. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD
23. Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals
24. New variant Creutzfeldt-Jakob disease in France
25. Screening slaughtered cattle for BSE
26. Diagnosis of bovine spongiform encephalopathy
27. Resistance of scrapie to decontamination
28. Scrapie strain differences: The implications of stability and mutation
29. Comparative analysis of scrapie agent inactivation methods
30. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
31. The key role of the nerve membrane protein PrP in scrapie-like diseases
32. Pathogenesis of mouse scrapie: Effect of route of inoculation on infectivity titres and dose-response curves
33. Pathogenesis of mouse scrapie: Dynamics of agent replication in spleen, spinal cord and brain after infection by different routes
34. Crystal structure of the human prions protein reveals a mechanism for oligomerisation
35. BSE transmission to macaques
36. Inactivation of the agents of scrapie, Creutzfeldt-Jakob disease, and kuru by radiations
37. Inactivation of the scrapie agent by near monochromatic ultraviolet light
38. Resistance of the scrapie agent to inactivation by psoralens
39. Evidence to implicate SAF as a form of the infectious agent
40. Abnormal fibrils from scrapie-infected brain
41. Tests for BSE evaluated
42. A cellular gene encodes scrapie PrP 27-30 protein
43. Prion protein genes: Evolutionary and functional aspects
44. Novel proteinaceous infectious particles cause scrapie
45. On the molecular structure of the scrapie agent
46. Transgenetic investigations of prion diseases of humans and animals
47. Molecular properties, partial purifications, and assay by incubation period measurements of the hamster scrapie agent
48. Scrapie agent contains a hydrophobic protein
49. On the biology of prions
50. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
51. Immunologic and molecular biologic studies of prion proteins in bovine spongiform encephalopathy
52. NMR structure of the mouse prion protein domain PrP (121-231)
53. NMR characterization of the full-length recombinant murine prion protein mPrP (23-231)
54. Autoclaving does not decontaminate formol-fixed scrapie tissues
55. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
56. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting
57. A novel progressive spongiform encephalopathy in cattle
58. Configurations and topographic distribution of PrP in the central nervous system in bovine spongiform encephalopathy: An immunohistochemical study
59. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy
60. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): An update
61. Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE)
62. A new variant of Creutzfeldt-Jakob disease in the UK
63. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation